To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a μ opioid agonist influence noxiously evoked c-fos expression in the rat? A pharmacological study

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 393-403

  Honoré, Prisca ^a,b   Chapman, Victoria ^a   Buritova, Jaroslava ^a   Besson, Jean Marie ^a  

^a Lab Physpharmacol du Syst Nerveux   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATIPAMEZOLE; CARRAGEENAN; MEDETOMIDINE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE EDEMA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; MALE; MEDETOMIDINE; MORPHINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID, MU;

EID: 0030441130     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. ABBADIE, C. AND BESSON, J. -M.: C-fos expression in lumbar spinal cord in the polyarthritic rat: Physiological and pharmacological aspects. In Neuropeptides, nociception and pain, ed. by T. Hökfelt, H. G. Schaible and R. F. Schmidt, 1994.
2. ABBADIE, C. AND BESSON, J. M.: C-fos expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis. Neuroscience 48: 985-993, 1992.
3. BELCHER, G., RYALL, R. W. AND SCHAFFNER, R.: The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurones in the cat. Brain Res. 151: 307-321, 1978.
4. CHAPMAN, V., HONORE, P., BURITOVA, J. AND BESSON, J.- M.: Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat. Neuroscience 67: 731-739, 1995.
5. CODERRE, T. J., CHAN, A. K., HELMS, C., BASBAUM, A. I. AND LEVINE, J. D.: Increasing sympathetic nerve terminal-dependent plasma extravasation correlates with decreased arthritic joint injury in rats. Neuroscience 40: 185-189, 1991.
6. DASHWOOD, M. R., GILBEY, M. P. AND SPYER, K. M.: The localisation of adrenoceptors and opiate receptors in regions of the cat central nervous system involved in cardiovascular control. Neuroscience 15: 537-551, 1985.
7. DICKENSON, A. H.: Where and how do opioids act? In Proceedings of the 7th World Congress on Pain, ed. by G. F. Gebhart, D. L. Hammond and T. S. Jensen, pp. 525-553, IASP Press, Seattle, 1994.
8. DICKENSON, A. H. AND SULLIVAN, A. F.: Combination therapy in analgesia: Seeking synergy. Cur. Opin. Anaesthesiol. 6: 861-865, 1993.
9. DRAISCI, G. AND IADAROLA, M. J.: Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6: 31-37, 1989.
10. FISHER, B., ZORNOW, M. H., YAKSH, T. L. AND PETERSON, B. M.: Antinociceptive properties of intrathecal dexmedetomidine in rats. Eur. J. Pharmacol. 192: 221-225, 1991.
11. FLAVAHAN, N. A.: The role of vascular α2-adrenoceptors as cutaneous thermosensors. N. I. P. S. 6: 251-255, 1991.
12. FLEETWOOD-WALKER, S. M., MITCHELL, R., HOPE, P. J., MOLONY, V. AND IGGO, A.: An α2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Res. 334: 243-254, 1985.
13. HARGREAVES, K., DUBNER, R., BROWN, F., FLORES, C. AND JORIS, J.: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88, 1988.
14. HEADLEY, P. M.: Noradrenergic receptors in the dorsal horn of the spinal cord. In Towards the Use of Noradrenergic Agonists for the Treatment of Pain, ed. by J. -M. Besson and G. Guilbaud, pp. 169-179, Excerpta Medica, Amsterdam-London-New York-Tokyo, 1992.
15. HEADLEY, P. M., DUGGAN, A. W. AND GRIERSMITH, B. T.: Selective reduction by noradrenaline and 5-hydroxytryptamine of nociceptive responses of cat dorsal horn neurones. Brain Res. 145: 185-189, 1978.
16. HOLE, K., ROSLAND, J. H., TJOLSEN, A., LUND, A. AND BERGE, O. -G.: The formalin test in mice: Influence of the ambient temperature (Abstract). Soc. Neurosc. 16: 564, 1990.
17. HONORE, P., BURITOVA, J. AND BESSON, J. -M.: Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: The effects of indomethacin. Eur. J. Pharmacol. 272: 249-259, 1995α.
18. HONORE, P., CHAPMAN, V., BURITOVA, J. AND BESSON, J. -M.: Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor. Br. J. Pharmacol. 114: 77-84, 1995b.
19. HONORE, P., BURITOVA, J., CHAPMAN, V. AND BESSON, J. -M.: Intraplantar morphine depresses spinal c-Fos expression induced during inflammatory pain states in the rat (Abstract). 25th Annual Meeting of the Society for Neuroscience 1995c.
20. HSU, S., RAINE, L. AND FANGER, H.: Use of avidin-biotin-peroxydase complex (ABC) in immunoperoxydase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577-580, 1981.
21. HUNT, S. P., PINI, A. AND EVAN, G.: Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature (Lond.) 328: 632-634, 1987.
22. HYLDEN, J. L. K., THOMAS, D. A., IADAROLA, M. J., NAHIN, R. L. AND DUBNER, R.: Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: Possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 194: 135-143, 1991.
23. IADAROLA, M. J., BRADY, L. S., DRAISCI, G. AND DUBNER, R.: Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioral parameters and opioid receptor binding. Pain 35: 313-326, 1988.
24. IDANPAAN-HEIKKILA, J. J., KALSO, E. A. AND SEPPALA, T.: Antinociceptive actions of dexmedetomidine and the κ-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli. J. Pharmacol. Exp. Ther. 271: 1306-1313, 1994.
25. JONES, S. L.: Noradrenergic modulation of noxious heat-evoked Fos-like immunoreactivity in the dorsal horn of the rat sacral spinal cord. J. Comp. Neurol. 325: 435-445, 1992.
26. JORIS, J., COSTELLO, A., DUBNER, R. AND HARGREAVES, K.: Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 43: 95-103, 1990.
27. KALSO, E. A., POYHIA, R. AND ROSENBERG, P. H.: Spinal antinociception by dexmedetomidine, a highly selective α-2-adrenergic agonist. Pharmacol. Toxicol. 168: 140-143, 1991.
28. KANUI, T. I., TJOLSEN, A., LUND, A., MJELLEM-JOLY, N. AND HOLE, K.: Antinociceptive effects of intrathecal administration of α-adrenoceptor antagonists and clonidine in the formalin test in the mouse. Neuropharmacology 32: 367-371, 1993.
29. KAYSER, V. AND GUILBAUD, G.: Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat. Pain 28: 99-107, 1987.
30. LEVINE, J. D. AND TAIWO, Y.: Inflammatory pain. In Textbook of Pain, ed. by P. D. Wall and R. Melzack, pp. 45-56, Churchill Livingstone, Edinburgh London Madrid Melbourne New York Tokyo, 1994.
31. LOOMIS, C. W., JHAMANDAS, K., MILNE, B. AND CERVENKO, F.: Monoamine and opioid interactions in spinal analgesia and tolerance. Pharmacol. Biochem. Behav. 26: 445-451, 1987.
32. LOOMIS, C. W., MILNE, B. AND CERVENKO, F. W.: A study of the interaction between clonidine and morphine on analgesia and blood pressure during continuous intrathecal infusion in the rat. Neuropharmacology 27: 191-199, 1988.
33. MALMBERG, A. B. AND YAKSH, T. L.: Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and isobolographic analysis of the NSAID interaction. Anesthesiology 79: 270-281, 1993.
34. MOLANDER, C., XU, Q. AND GRANT, G.: The cytoarchitectonic organization of the spinal cord in the rat: I. The lower thoracic and lumbosacral cord. J. Comp. Neurol. 230: 133-141, 1984.
35. MONASKY, M. S., ZINSMEISTER, A. R., STEVENS, C. W. AND YAKSH, T. L.: Interaction of intrathecal morphine and ST91 on antinociception in the rat: Doseresponse analysis, antagonism and clearance. J. Pharmacol. Exp. Ther. 234: 383-392, 1990.
36. MORGAN, J. I. AND CURRAN, T.: Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14: 421-451, 1991.
37. NAKAMURA, M. AND FERREIRA, S. H.: Peripheral analgesic action of clonidine: Mediation by release of endogenous enkephalin-like substances. Eur. J. Pharmacol. 146: 223-228, 1988.
38. NICHOLAS, A. P., PIERIBONE, V. AND HÖKFELT, T.: Distribution of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: An in situ hybridization study. J. Comp. Neurol. 328: 575-594, 1993.
39. NOGUCHI, K., DUBNER, R. AND RUDA, M. A.: Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is colocalized with Fos and Fos-related proteins. Neuroscience 46: 561-570, 1992.
40. NOGUCHI, K., KOWALSKI, K., TRAUB, R., SOLODKIN, A., IADAROLA, M. J. AND RUDA, M. A.: Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Mol. Brain Res. 10: 227-233, 1991.
41. NORTH, R. A. AND YOSHIMURA, M.: The actions of noradrenaline on neurones of the rat substantia gelatinosa in vitro. J. Physiol. 349: 43-55, 1984.
42. OSSIPOV, M. H., HARRIS, S., LLOYD, P. AND MESSINEO, E.: An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. J. Pharmacol. Exp. Ther. 255: 1107-1116, 1990a.
43. OSSIPOV, M. H., HARRIS, S., LLOYD, P., MESSINEO, E., LIN, B. -S. AND BAGLEY, J.: Antinociceptive interaction between opioids and medetomidine: Systemic additivity and spinal synergy. Anesthesiology 73: 1227-1235, 1990b.
44. PERTOVAARA, A.: Antinociception in bulboreticular neurons of the rat produced by spinally administered medetomidine, an α2-adrenoceptor agonist. Eur. J. Pharmacol. 204: 9-14, 1991.
45. PERTOVAARA, A.: Antinociception induced by alpha-2-adrenoceptor agonists, with special emphasis on medetomidine studies. Progress in Neurobiology 40: 691-709, 1993.
46. PERTOVAARA, A., BRAVO, R. AND HERDEGEN, T.: Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation. Neuroscience 54: 117-126, 1993.
47. PERTOVAARA, A., KAUPILA, T., JYVÄSJÄRVI, E. AND KALSO, E.: Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception. Neuroscience 44: 705-714, 1991.
48. PERTOVAARA, A., KAUPPILA, T. AND TUKEVA, T.: The effect of medetomidine, an α2-adrenoceptor agonist, in various pain tests. Eur. J. Pharmacol. 179: 323-328, 1990.
49. PROUDFIT, H. K.: Pharmacologic evidence for the modulation of nociception by noradrenergic neurons. In Progress in Brain Research, ed. by H. L. Fields and J.-M. Besson, pp. 357-370, Elsevier Science Publishers B.V., 1988.
50. PUKE, M. J. C. AND WIESENFELD-HALLIN, Z.: The differential effects of morphine and the a2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain. Anesth. Analg. 77: 104-109, 1993.
51. RANG, H. P., BEVAN, S. AND DRAY, A.: Chemical activation of nociceptive peripheral neurons. British Medical Bulletin 47: 534-548, 1991.
52. REDDY, S. V. R., MADERDRUT, J. L. AND YAKSH, T. L.: Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J. Pharmacol. Exp. Ther. 213: 525-533, 1980.
53. REDDY, S. V. R. AND YAKSH, T. L.: Spinal noradrenergic terminal system mediates antinociception. Brain Res. 189: 391-401, 1980.
54. REIMANN, W. AND SCHNEIDER, F.: Presynaptic a2-adrenoceptors modulate the release of (3H)noradrenaline from rat spinal cord dorsal horn neurones. Eur. J. Pharmacol. 167: 161-166, 1989.
55. ROSIN, D. L., ZENG, D., STORNETTA, R. L., NORTON, F. R., RILEY, T., OKUSA, M. D., GUYENET, P. G. AND LYNCH, K. R.: Immunohistochemical localization of α2A-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat. Neuroscience 56: 139-155, 1993.
56. SABBE, M. B., PENNING, J. P., OZAKI, G. T. AND YAKSH, T. L.: Spinal and systemic action of the α2 receptor agonist dexmedetomidine in dogs. Anesthesiology 80: 1057-1072, 1994.
57. SAGEN, J. AND PROUDFIT, H. K.: Effect of intrathecally administered noradrenergic antagonists on nociception in the rat. Brain Res. 310: 295-301, 1984.
58. SATOH, M., KAWAJIRI, S. -T., UKAI, Y. AND YAMAMOTO, M.: Selective and non-selective inhibition by enkephalins and noradrenaline of nociceptive response of laminae V type neurons in the spinal dorsal horn of the rabbit. Brain Res. 177: 384-387, 1979.
59. SAVOLA, J. -M., RUSKOAHO, H., PUURUNEN, J., SALONEN, J. S. AND KAHKI, N. T.: Evidence for medetomidine as a selective and potent agonist at α2-adrenoceptors. J. Auton. Pharmac. 5: 275-284, 1986.
60. SEYBOLD, V. S. AND ELDE, R. P.: Receptor autoradiography in thoracic spinal cord: Correlation of neurotransmitter binding sites with sympathoadrenal neurons. J. Neurosci. 4: 2533-2542, 1984.
61. SOLOMON, R. E. AND GEBHART, G. F.: Intrathecal morphine and clonidine: Antinociceptive tolerance and cross-tolerance and effects on blood pressure. J. Pharmacol. Exp. Ther. 245: 444-454, 1988.
62. SOLOMON, R. E. AND GEBHART, G. F.: Synergistic antinociceptive interactions among drugs administered to the spinal cord. Anesth. Analg. 78: 1164-1172, 1994.
63. STANFA, L. C. AND DICKENSON, A. H.: Enhanced alpha-2 adrenergic controls and spinal morphine potency in inflammation. Neuroreport 5: 469-472, 1994.
64. SULLIVAN, A. F., DASHWOOD, M. R. AND DICKENSON, A. H.: α-2-adrenoceptor modulation of nociception in rat spinal cord: Location, effects and interactions with morphine. Eur. J. Pharmacol. 138: 169-177, 1987.
65. SULLIVAN, A. F., KALSO, E. A., MCQUAY, H. J. AND DICKENSON, A. H.: The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat. Eur. J. Pharmacol. 215: 127-133, 1992a.
66. 2-adrenergic antinociception in the rat spinal cord. Neurosci. Lett. 139: 65-68, 1992b.
67. TAKANO, Y., TAKANO, M. AND YAKSH, T. L.: The effect of intrathecally administered imiloxan and WB4101: Possible role of α2-adrenoceptor subtypes in the spinal cord. Eur. J. Pharmacol. 219: 466-468, 1992,
68. THOMAS, D. A., ANTON, F., KENSHALO, D. R., WILLIAMS, G. M. AND DUBNER, R.: Noradrenergic and opioid systems interact to alter the detection of noxious thermal stimuli and facial scratching in monkeys. Pain 55: 63-70, 1993.
69. UHLEN, S. AND WIKBERG, E. S.: Rat spinal cord α2-adrenoceptors are of the α2A-subtype: Comparison with α2A- and α2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding. Pharmacol. Toxicol. 89: 341-350, 1991.
70. UNNERSTALL, J. R., KOPAJTIC, T. A. AND KUHAR, M. J.: Distribution of a2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res. Rev. 7: 69-101, 1984.
71. VIRTANEN, R., SAVOLA, J. -M. AND SAANO, V.: Highly selective and specific antagonism of central and peripheral α2-adrenoceptors by atipamezole. Arch. Int. Pharmacodyn. 297: 190-204, 1989.
72. VIRTANEN, R., SAVOLA, J. -M., SAANO, V. AND NYMAN, L.: Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist. Eur. J. Pharmacol. 150: 9-14, 1988.
73. WILCOX, G. L., CARLSSON, K. H., JOCHIM, A. AND JURNA, I.: Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord. Brain Res. 405: 84-95, 1987.
74. WINTER, C. A., RISLKY, E. A. AND NUSS, G. W.: Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111: 544-547, 1962.
75. YAKSH, T. L.: Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol. Biochem. Behav. 22: 845-858, 1985.
76. YAKSH, T. L. AND REDDY, V. R.: Studies in the primate on the analgesic effects associated with intrathecal actions of opiates, α-adrenergic agonists and baclofen. Anesthesiology 54: 451-467, 1981.
77. YOUNG, W. S. III. AND KUHAR, M. J.: Noradrenergic α1 and α2 receptors: Light microscopic autoradiographic localization. Proc. Natl. Acad. Sci. U.S.A. 77: 1696-1980, 1980.
78. ZIEGLGANSBERGER, W. AND TOLLE, T. R.: The pharmacology of pain signalling. Curr. Opin. Neurobiol. 3: 611-618, 1993.
79. ZIMMERMANN, M.: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.